The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Morning Seminar

MS3-3

The history of ALL treatment and the role of Besponsa

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.3 (Osaka International Convention Center, 12F Conference Hall)

Chair: Yoshinobu Maeda (Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Hematology, Oncology and Respiratory Medicine)

Sponsor: Pfizer Japan Inc.

[MS3-3] The history of ALL treatment and the role of Besponsa

Hirohisa Nakamae (Hematology, Graduate School of Medecine Osaka City University)